20.61
0.29%
0.06
Dopo l'orario di chiusura:
20.61
Precedente Chiudi:
$20.55
Aprire:
$20.3
Volume 24 ore:
1.70M
Relative Volume:
2.05
Capitalizzazione di mercato:
$1.11B
Reddito:
$312.78M
Utile/perdita netta:
$-143.56M
Rapporto P/E:
-13.21
EPS:
-1.56
Flusso di cassa netto:
$1.22M
1 W Prestazione:
-9.84%
1M Prestazione:
-7.87%
6M Prestazione:
+47.53%
1 anno Prestazione:
+90.48%
Caredx Inc Stock (CDNA) Company Profile
Nome
Caredx Inc
Settore
Industria
Telefono
415-287-2300
Indirizzo
8000 MARINA BLVD, BRISBANE, CA
Confronta CDNA con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
20.61 | 1.11B | 312.78M | -143.56M | 1.22M | -2.69 |
TMO
Thermo Fisher Scientific Inc
|
524.05 | 200.45B | 42.37B | 6.14B | 7.78B | 15.95 |
DHR
Danaher Corp
|
228.55 | 165.08B | 23.74B | 3.89B | 4.98B | 5.24 |
A
Agilent Technologies Inc
|
134.51 | 38.36B | 6.51B | 1.29B | 1.37B | 4.42 |
IQV
Iqvia Holdings Inc
|
197.27 | 35.80B | 15.32B | 1.41B | 1.96B | 7.62 |
IDXX
Idexx Laboratories Inc
|
412.26 | 33.76B | 3.84B | 866.24M | 792.60M | 10.37 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-08-28 | Iniziato | Wells Fargo | Underweight |
2024-08-19 | Aggiornamento | BTIG Research | Neutral → Buy |
2024-05-13 | Downgrade | Raymond James | Outperform → Mkt Perform |
2024-05-01 | Aggiornamento | Craig Hallum | Hold → Buy |
2023-11-09 | Aggiornamento | Stephens | Equal-Weight → Overweight |
2023-08-15 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2023-05-11 | Downgrade | BTIG Research | Buy → Neutral |
2023-03-07 | Downgrade | Stephens | Overweight → Equal-Weight |
2023-03-03 | Downgrade | Craig Hallum | Buy → Hold |
2023-03-03 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
2022-04-25 | Iniziato | Stephens | Overweight |
2021-07-20 | Ripresa | BTIG Research | Buy |
2021-06-03 | Iniziato | Goldman | Buy |
2021-02-26 | Downgrade | H.C. Wainwright | Buy → Neutral |
2020-10-30 | Reiterato | H.C. Wainwright | Buy |
2020-10-08 | Reiterato | H.C. Wainwright | Buy |
2020-10-02 | Reiterato | H.C. Wainwright | Buy |
2020-08-05 | Reiterato | H.C. Wainwright | Buy |
2020-06-26 | Iniziato | BTIG Research | Buy |
2020-06-19 | Reiterato | H.C. Wainwright | Buy |
2019-10-01 | Ripresa | Craig Hallum | Buy |
2019-05-09 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
2019-02-15 | Iniziato | Jefferies | Buy |
2018-10-23 | Ripresa | Raymond James | Strong Buy |
2018-09-18 | Reiterato | H.C. Wainwright | Neutral |
2017-11-27 | Iniziato | H.C. Wainwright | Buy |
2016-06-14 | Reiterato | Mizuho | Buy |
2015-09-29 | Downgrade | Raymond James | Outperform → Mkt Perform |
2015-09-25 | Iniziato | Craig Hallum | Buy |
2015-03-18 | Reiterato | Mizuho | Buy |
Mostra tutto
Caredx Inc Borsa (CDNA) Ultime notizie
Public Employees Retirement System of Ohio Sells 38,966 Shares of CareDx, Inc (NASDAQ:CDNA) - MarketBeat
State Street Corp Has $63.58 Million Holdings in CareDx, Inc (NASDAQ:CDNA) - MarketBeat
CareDx to Present at J.P. Morgan Healthcare Conference 2025: Transplant Medicine Innovation Spotlight - StockTitan
Lord Abbett & CO. LLC Acquires New Stake in CareDx, Inc (NASDAQ:CDNA) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires New Holdings in CareDx, Inc (NASDAQ:CDNA) - MarketBeat
CareDx, Inc (NASDAQ:CDNA) Sees Large Increase in Short Interest - MarketBeat
Janus Henderson Group PLC Buys New Position in CareDx, Inc (NASDAQ:CDNA) - MarketBeat
Virtue Capital Management LLC Invests $755,000 in CareDx, Inc (NASDAQ:CDNA) - MarketBeat
CareDx expands into hematology oncology with new trial By Investing.com - Investing.com Nigeria
Analysts Set CareDx, Inc (NASDAQ:CDNA) Target Price at $29.60 - MarketBeat
CareDx guides Q3 revenue above estimates - MSN
TC BioPharm And CareDx Partner To Advance AML Therapy Trial - Contract Pharma
CareDx expands into hematology oncology with new trial - Investing.com India
CareDx Partners with TC BioPharm to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy - BioSpace
TC BioPharm Partners with CareDx for Breakthrough AML Cell Therapy TrialKey Clinical Milestone - StockTitan
CareDx, Inc (NASDAQ:CDNA) Shares Purchased by Fmr LLC - MarketBeat
TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy - Yahoo Finance
BNP Paribas Financial Markets Buys 46,798 Shares of CareDx, Inc (NASDAQ:CDNA) - MarketBeat
Castleark Management LLC Makes New Investment in CareDx, Inc (NASDAQ:CDNA) - MarketBeat
256,580 Shares in CareDx, Inc (NASDAQ:CDNA) Bought by Point72 Asset Management L.P. - MarketBeat
CareDx's secretary and general counsel sells shares worth $49,842 By Investing.com - Investing.com Australia
CareDx's secretary and general counsel sells shares worth $49,842 - Investing.com
CareDx Inc (CDNA) Shares Up 3.22% on Dec 4 - GuruFocus.com
Jacobs Levy Equity Management Inc. Sells 363,324 Shares of CareDx, Inc (NASDAQ:CDNA) - MarketBeat
Caredx director Peter Maag sells $125,000 in stock By Investing.com - Investing.com Canada
Caredx director Peter Maag sells $125,000 in stock - Investing.com
Has CareDx (CDNA) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Possible Bearish Signals With CareDx Insiders Disposing Stock - Simply Wall St
CareDx Inc (CDNA) Shares Up 3.06% on Dec 2 - GuruFocus.com
CareDx, Inc (NASDAQ:CDNA) Shares Sold by Bank of Montreal Can - MarketBeat
Bellevue Group AG Sells 767,119 Shares of CareDx, Inc (NASDAQ:CDNA) - MarketBeat
CareDx, Inc (NASDAQ:CDNA) Shares Acquired by Fred Alger Management LLC - MarketBeat
Algert Global LLC Invests $892,000 in CareDx, Inc (NASDAQ:CDNA) - MarketBeat
Higher-Than-Anticipated Reimbursement Rates Lifted CareDx (CDNA) - Insider Monkey
Dynamic Technology Lab Private Ltd Makes New $681,000 Investment in CareDx, Inc (NASDAQ:CDNA) - MarketBeat
Wall Street Analysts Predict a 49.89% Upside in CareDx (CDNA): Here's What You Should Know - MSN
CareDx Inc (CDNA) Trading 6.16% Higher on Oct 2 - GuruFocus.com
Connor Clark & Lunn Investment Management Ltd. Raises Holdings in CareDx, Inc (NASDAQ:CDNA) - MarketBeat
After Plunging -11.97% in 4 Weeks, Here's Why the Trend Might Reverse for CareDx (CDNA) - MSN
CareDx Inc (CDNA) Trading 1.84% Higher on Nov 19 - GuruFocus.com
Are Medical Stocks Lagging CareDx (CDNA) This Year? - MSN
CareDx, Inc (NASDAQ:CDNA) Receives $29.60 Consensus Price Target from Analysts - MarketBeat
Sumitomo Mitsui Trust Group Inc. Reduces Holdings in CareDx, Inc (NASDAQ:CDNA) - MarketBeat
Los Angeles Capital Management LLC Cuts Stock Position in CareDx, Inc (NASDAQ:CDNA) - MarketBeat
CareDx Inc (CDNA) Shares Up 4.16% on Nov 13 - GuruFocus.com
CDNACareDx, Inc. Latest Stock News & Market Updates - StockTitan
CareDx to Participate in Upcoming Investor Conferences - Business Wire
CareDx, Inc (NASDAQ:CDNA) Q3 2024 Earnings Call Transcript - MSN
Nikko Asset Management Americas, Inc. Reduces Stake in CareDx Inc - GuruFocus.com
(CDNA) On The My Stocks Page - Stock Traders Daily
Caredx Inc Azioni (CDNA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):